Trial Profile
A retrospective trial of ipilimumab in treatment-naive advanced melanoma patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 11 Dec 2015 New trial record